The kits enable researchers to use preferred cell models of their choices, including the homogeneous time resolved fluorescence (HTRF) guanosine-5'-triphosphate (GTP) Gi binding kit, the industry's first time-resolved fluorescence energy transfer (TR-FRET)-based assay for GTP binding, as well as the B-arr2 recruitment kit and HTRF total kits for B-Arrestin 1, B-Arrestin 2 and AP2.

Using these tests will help scientists understand the role GPCRs play in disease by studying the interaction, expression, and potential modulation of intracellular proteins involved in their signaling mechanisms.

PerkinElmer unveils LC 300 platform, SimplicityChrom software
PerkinElmer has debuted its LC 300 platform and SimplicityChrom software, a package designed to combine high-performance liquid chromatography and ultrahigh-performance...

PerkinElmer debuts ChemOffice+ Cloud
PerkinElmer has introduced ChemOffice+ Cloud, a new application for its ChemDraw chemistry drawing software portfolio.

PerkinElmer to acquire Horizon Discovery for $383M
PerkinElmer has reached an agreement to acquire Horizon Discovery Group with an all-cash offer of approximately $383 million. The transaction is...

PerkinElmer introduces no-wash immunoassay for mitophagy dysfunction
PerkinElmer has debuted a no-wash ubiquitin phosphorylation at serine 65 immunoassay for studying defective mitophagy dysfunction associated with Parkinson's...

PerkinElmer launches workstations for COVID-19 detection
PerkinElmer has launched a series of new workstations for SARS-CoV-2 testing.